@RobClarkeLab @ismenasg @DrRachelEyre @DrDAlferez @asimslab @BreastCancerNow @ManchesterBRC @TheChristie Congratulations Rob! This is really exciting as we @TracyRobsonMCT showed that our #FKBPL peptides target STAT3 signalling in #OvarianCancer https://t.
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer #stemcells and #breastcancer #metastasis by downregulating DLL4 and Notch4 https://t.co/2yu3XQ66Cx
New from #The_MRC https://t.co/Hu6MdpTVRV FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
RT @BMC_series: Editor's Pick #BMCCancer: Robson and her colleagues @MCT_RSCI @UTS_Science present, for the first time, pre-clinical activi…